HHS inspector: Mylan may have overcharged taxpayers by $1.2B for EpiPens
Wednesday, May 31, 2017 - 20:31
in Mathematics & Economics
New evidence suggests taxpayers overpaid Mylan, maker of EpiPens, a total of $1.27 billion for anti-allergy devices over the last ten years.